HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takkenberg, J.J.M. Articles by Bogers, A.J.J.C. Search for Related Content PubMed PubMed Citation Articles by Takkenberg, J.J.M. Articles by Bogers, A.J.J.C. Related Collections Valve disease

Eur J Cardiothorac Surg 2002;21:683-691
© 2002 Elsevier Science NL

Evolution of allograft aortic valve replacement over 13 years: results of 275 procedures

^a Department of Cardio-Thoracic Surgery, Bd162 and the Center for Clinical Decision Making, Erasmus Medical Center Rotterdam, P.O. Box 2040, 3000CA Rotterdam, The Netherlands
^b Department of Public Health, Erasmus Medical Center Rotterdam, P.O. Box 2040, 3000CA Rotterdam, The Netherlands

Received 14 September 2001; received in revised form 14 December 2001; accepted 3 January 2002.

* Corresponding author. Tel.: +31-10-463-5413; fax: +31-10-463-3993
e-mail: takkenberg{at}thch.azr.nl

Objective: We describe our center's experience with the use of allografts for aortic valve or root replacement, illustrating the impact on outcome of the changes made in surgical and preservation techniques. Methods: Between 4/1987 and 1/2001 275 allografts were used in 267 consecutive patients to replace the aortic valve or root. All patients were prospectively followed over time. Mean patient age was 46 years (SD 16; range 0.06–83), male/female ratio was 201/74. Prior cardiac operations took place in 73 patients; 49 patients presented with active endocarditis. Pre-operative NYHA-class was III in 51%. Initially, the subcoronary technique was used (SC; N=95) while in recent years root replacement (ARR; N=180) became the technique of choice. Seven fresh (two pulmonary and five aortic) and 268 cryopreserved (four pulmonary and 264 aortic; 35 glycerol and 233 DMSO) allografts were implanted. Concomitant procedures took place in 133 (48%). Results: Operative mortality was 5.5% (N=15) and during follow-up (99% complete) 29 more patients died. Overall cumulative survival was 73% (95% CI 65–81%) at 9 years postoperative and significantly better for SC compared to ARR patients (P=0.005). Freedom from allograft-related reoperation (N=34) was 77% (95% CI 69–85) at 9 years, and worse in the SC compared to ARR group due to increased early technical failure (P=0.03). Freedom from reoperation for structural valve deterioration (SVD; N=22) was 81% (95% CI 73–89) at 9 years and did not differ between SC and ARR (P=0.51). Independent predictors of degenerative SVD were younger patient age (HR 0.93 with age as continuous variable; 95% CI 0.90–0.97), older donor age (HR 1.06 with age as a continuous variable; 95% CI 1.00–1.11), larger allograft diameter (HR 1.38; 95% CI 1.11–1.71) and the use of pulmonary allografts (HR 10.72; 95% CI 3.88–29.63). Calculated median time to reoperation for structural valve deterioration ranged from 23 years in a 65-year-old patient to 12 years in a 25-year-old. Conclusions: Aortic valve replacement with allografts yields adequate midterm results. Although important changes have been made over the years to improve durability, allografts still have a limited life span especially in young patients.

Key Words: Allograft • Aortic valve replacement • Surgical technique • Preservation technique

This article has been cited by other articles:

				A. Ali, Y. Abu-Omar, A. Patel, A. Y. Sheikh, Z. Ali, A. Saeed, A. Akhtar, T. Athanasiou, and J. Pepper Propensity analysis of survival after subcoronary or root replacement techniques for homograft aortic valve replacement. J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 334 - 341. [Abstract] [Full Text] [PDF]

				A. Ali, Y. Abu-Omar, A. Patel, Z. Ali, A. Y. Sheikh, A. Akhtar, A. Pavlovic, P. Theodorou, T. Athanasiou, and J. Pepper Valve failure following homograft aortic valve replacement: does implantation technique have an effect? Eur. Heart J., June 1, 2008; 29(11): 1454 - 1462. [Abstract] [Full Text] [PDF]

				J. J.M. Takkenberg, L. M.A. Klieverik, J. A. Bekkers, A. P. Kappetein, J. W. Roos, M. J.C. Eijkemans, and A. J.J.C. Bogers Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 851 - 859. [Abstract] [Full Text] [PDF]

				H. J. Geissler, U. M. Fischer, S. Foerster, A. Krahwinkel, A. Antonyan, A. Kroener, K. Addicks, U. Mehlhorn, and W. Bloch Effect of Thawing on Nitric Oxide Synthase III and Apoptotic Markers in Cryopreserved Human Allografts Ann. Thorac. Surg., November 1, 2006; 82(5): 1742 - 1746. [Abstract] [Full Text] [PDF]

				A. P. Kappetein, J. J.M. Takkenberg, J. P.A. Puvimanasinghe, W.R. E. Jamieson, M. Eijkemans, and Ad.J.J.C. Bogers Does the type of biological valve affect patient outcome? Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 398 - 402. [Abstract] [Full Text] [PDF]

				T. Athanasiou, C. Jones, R. Jin, G. L. Grunkemeier, and D. N. Ross Homograft Implantation Techniques in the Aortic Position: To Preserve or Replace the Aortic Root? Ann. Thorac. Surg., May 1, 2006; 81(5): 1578 - 1585. [Abstract] [Full Text] [PDF]

				A. Kaya, M. A. Schepens, W. J. Morshuis, R. H. Heijmen, A. Brutel De La Riviere, and K. M. Dossche Valve-Related Events After Aortic Root Replacement With Cryopreserved Aortic Homografts Ann. Thorac. Surg., May 1, 2005; 79(5): 1491 - 1495. [Abstract] [Full Text] [PDF]

				F. Dagenais, P. Cartier, P. Voisine, D. Desaulniers, J. Perron, R. Baillot, G. Raymond, J. Metras, D. Doyle, and P. Mathieu Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1041 - 1049. [Abstract] [Full Text] [PDF]

				J.-M. Grinda, J.-L. Mainardi, N. D'Attellis, M.-O. Bricourt, A. Berrebi, J.-N. Fabiani, and A. Deloche Cryopreserved Aortic Viable Homograft for Active Aortic Endocarditis Ann. Thorac. Surg., March 1, 2005; 79(3): 767 - 771. [Abstract] [Full Text] [PDF]

				B. Iung, G. Baron, E. G. Butchart, F. Delahaye, C. Gohlke-Barwolf, O. W. Levang, P. Tornos, J.-L. Vanoverschelde, F. Vermeer, E. Boersma, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease Eur. Heart J., July 1, 2003; 24(13): 1231 - 1243. [Abstract] [Full Text] [PDF]